Neonatal Procalcitonin Intervention Study (NeoPInS)
Effect of Procalcitonin-guided Decision Making on Duration of Antibiotic Therapy in Suspected Neonatal Early-onset Sepsis: Multicenter Prospective Randomized Intervention Study
Sponsor: Amsterdam UMC, location VUmc
A NA clinical study on Sepsis, this trial is ongoing. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 11 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Apr 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Apr 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status NA
-
May 2022 — Jul 2023 [monthly]
Unknown Status NA
▶ Show 6 earlier versions
-
Oct 2021 — May 2022 [monthly]
Unknown Status NA
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status NA
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status NA
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status NA
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Atrium Medisch Centrum, Heerlen
- Erasmus Medical Center
- Flevo Ziekenhuis, Almere
- Ijssalland Ziekenhuis, Capelle aan den Ijssel
- Insel Gruppe AG, University Hospital Bern
- Jeroen Bosch Ziekenhuis, s'-Hertogenbosch
- Kantonsspital Graubuenden
- Kantonsspital Winterthur KSW
- Luzerner Kantonsspital
- McMaster University
- Reinier de Graaf Groep
- Sint Franciscus Gasthuis
- St. Joseph's Healthcare Hamilton
- Thomayer University Hospital
- Triemli Hospital
- Vlietland Ziekenhuis
For direct contact, visit the study record on ClinicalTrials.gov .